Liberation Labs Taps Biotech Biomanufacturing Veteran Rhys Dale to Assist with Development & Operations of Flagship Facility
RICHMOND, Ind., March 13, 2024 (GLOBE NEWSWIRE) -- Liberation Labs has appointed Rhys Dale as Site Director for its flagship biomanufacturing facility currently being constructed in Richmond.
- RICHMOND, Ind., March 13, 2024 (GLOBE NEWSWIRE) -- Liberation Labs has appointed Rhys Dale as Site Director for its flagship biomanufacturing facility currently being constructed in Richmond.
- Dale has deep expertise in process conceptualization/design, technology development/scale-up, techno-economic process modeling, permitting, project development, and manufacturing.
- Liberation Labs is currently constructing a commercial-scale, purpose-built, precision fermentation biomanufacturing facility with a capacity of 600,000 liters and a fully dedicated downstream process (DSP).
- “Rhys is a proven leader in scaling biotechnology through biomanufacturing development and operations, and it’s great to have him on board at this time in the project’s lifecycle,” said Mark Warner, co-founder and CEO of Liberation Labs.